Kamiren (Doxazosin)

Doxazosin, the active ingredient in Kamiren, is an alpha‑1 adrenergic blocker presented as a tablet for oral use. It is employed to lower elevated blood pressure and to relieve urinary obstruction caused by an enlarged prostate in adult patients. GNH USA supplies Kamiren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Doxazosin acts on the alpha‑1 adrenergic receptor pathway to manage cardiovascular and urological conditions. - Hypertension: reduces systemic vascular resistance, helping to achieve target blood pressure levels. - Benign prostatic hyperplasia (BPH): relaxes smooth muscle in the prostate and bladder neck, improving urinary flow and reducing symptoms. - Cardiovascular risk management: used as part of combination therapy to lower the risk of hypertension‑related complications.

Doxazosin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Nasal congestion: stuffy or runny nose. - Peripheral edema: swelling of ankles or feet. - Nausea: upset stomach.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure, potentially causing fainting. - Syncope: sudden loss of consciousness. - Priapism: prolonged, painful erection requiring urgent care. - Angioedema: rapid swelling of face, lips, or throat. - Allergic reaction: rash, itching, or anaphylaxis. - Liver injury: abnormal liver function tests.

Before initiating therapy with Doxazosin, certain safety considerations should be observed. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Renal function assessment: adjust use in patients with impaired kidney function. - Hepatic impairment: use cautiously in moderate to severe liver disease. - Concomitant antihypertensives: evaluate risk of additive blood‑pressure lowering effects. - Sudden discontinuation: taper dose to prevent rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Doxazosin can interact with several medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Other alpha‑1 blockers (e.g., prazosin, terazosin): may cause additive hypotensive effects. - Potent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase plasma concentrations, raising risk of adverse events. - Strong antihypertensive combinations (e.g., nitroprusside): can precipitate severe hypotension.

Moderate Interactions (Monitor Closely):\n- Diuretics (e.g., furosemide): may enhance orthostatic hypotension. - NSAIDs (e.g., ibuprofen): can blunt antihypertensive response. - CYP3A4 inducers (e.g., rifampicin): may reduce drug exposure. - Sildenafil or other PDE5 inhibitors: increase risk of symptomatic hypotension.